Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | +6.35% | +23.08% | -33.57% |
Mar. 18 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
Mar. 15 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 40.7M | Sales 2025 * | 49.94M | Capitalization | 9.36M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -3M | EV / Sales 2024 * | 0.23 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.19 x |
P/E ratio 2024 * |
-0.57
x | P/E ratio 2025 * |
-3.38
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.65% |
Latest transcript on Biofrontera Inc.
1 day | +6.35% | ||
1 week | +23.08% | ||
1 month | +19.48% | ||
3 months | +38.35% | ||
6 months | -60.85% | ||
Current year | -33.57% |
Managers | Title | Age | Since |
---|---|---|---|
Hermann Lübbert
CEO | Chief Executive Officer | 68 | 15-02-28 |
Fred Leffler
DFI | Director of Finance/CFO | 41 | 22-10-23 |
Erica Gates
DFI | Director of Finance/CFO | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Borer
BRD | Director/Board Member | 67 | 21-11-01 |
Hermann Lübbert
CEO | Chief Executive Officer | 68 | 15-02-28 |
Kevin D. Weber
BRD | Director/Board Member | 66 | 22-03-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 1.84 | +6.35% | 36,593 |
24-04-29 | 1.73 | +8.81% | 75,717 |
24-04-26 | 1.59 | -5.92% | 50,733 |
24-04-25 | 1.69 | +1.81% | 26,034 |
24-04-24 | 1.66 | +11.04% | 62,969 |
Delayed Quote Nasdaq, April 30, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.57% | 9.36M | |
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- BFRI Stock